Drug Profile
SPW 5186
Alternative Names: SP/W 5186; SPM 5186Latest Information Update: 30 Apr 2001
Price :
$50
*
At a glance
- Originator Schwarz Pharma
- Developer GlaxoSmithKline; Schwarz Pharma
- Class Organic nitrates
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris
Most Recent Events
- 30 Apr 2001 Discontinued-II for Angina pectoris in Germany (PO)
- 30 Apr 2001 Discontinued-II for Angina pectoris in United Kingdom (PO)
- 30 Apr 2001 Discontinued-Preclinical for Angina pectoris in Canada (PO)